<DOC>
	<DOCNO>NCT01336751</DOCNO>
	<brief_summary>Study Primary Objectives : To compare glycemic control , measure hemoglobin A1c ( A1C ) , insulin glargine 75 % insulin lispro protamine suspension/25 % insulin lispro add-on therapy subject fail oral combination therapy sulfonylurea metformin . Study Secondary Objectives : To compare follow measure subject receive insulin glargine 75 % insulin lispro protamine suspension/25 % insulin lispro : - Incidence hypoglycemia - Change weight - Change serum lipid profile - Percentage subject achieve A1C level ≤7 %</brief_summary>
	<brief_title>Lantus Versus Humalog Mix add-on Therapy Type Diabetes Patients Failing Sulfonylurea Metformin Combination Treatment</brief_title>
	<detailed_description>The plan duration enrollment 6 month . The study consist 2 week screen phase study period plan 24 week .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<mesh_term>Protamines</mesh_term>
	<criteria>Patients must give sign informed consent . Males females 18 79 year age . Diagnosis type 2 diabetes mellitus least one year . Patients must continuous oral hypoglycemic treatment least three month use dosing : least half maximally label dose sulfonylurea + least 1000 mg metformin daily . HBA1C ≥ 8 % ≤11 % , inclusive , measure screening ( visit 1 ) . Patients must BMI &gt; 25 kg/m2 baseline Willingness accept , demonstrate ability inject insulin glargine 75 % insulin lispro protamine suspension 25 % insulin lispro injection therapy . Ability willingness perform SMBG profile use plasma glucose meter least twice day . Patients must able understand willing adhere compliant study protocol Patients , stroke , MI , coronary artery bypass graft ( CABG ) , percutaneous transluminal coronary angioplasty ( PTCA ) angina pectoris within last 12 month . Patients congestive heart failure require pharmacological treatment . Patients nonselective beta blocker ( include ocular ) . Patients impaired renal function , show limited serum creatinine ≥ 1.5 mg/dl ( 133μmol/L ) male , ≥ 1.4 mg/dl ( 124 μmol/L ) female . Patients acute infection . Patients diagnosis dementia . Treatment systemic steroid large dos inhale steroid . Patients acute chronic metabolic acidosis , include diabetic ketoacidosis . Patients plan radiological examination require administration contrast agent . Clinical evidence active liver disease , serum ALT 2.5 time upper limit normal range . Patients history hypoglycemia unawareness . Pregnant lactating female . Failure use adequate contraception ( woman current reproductive potential ) . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>